US Stocks

Kymera Therapeutics, Inc.

Kymera Therapeutics is a biopharmaceutical company that focuses on discovering and developing new small molecule therapeutics. Their programs are aimed at treating various diseases, including immunology-inflammation diseases such as rheumatoid arthritis, hematologic malignancies, solid tumors, and autoimmune diseases. Established in 2015, Kymera is headquartered in Watertown, Massachusetts.